Interventional Oncology Market to Reach $2.9 billion by 2024 | Emerging Economies Offer High Growth Potential

According to the new market research report "Interventional Oncology Market by Product (Radiofrequency, microwave, cryoablation, embolization, guidewires), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis) - Global Forecast to 2024", published by MarketsandMarkets™, the Interventional Oncology Market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 6.8%.

Don't miss out on business opportunities in Interventional Oncology Market

Rising preference for minimally invasive procedures, increasing public-private funding and government support for cancer research, technological advancements in the field of interventional oncology, and increasing government investments and funding for interventional oncology and related cancer research are some of the major factors driving the growth of this market.

The TARE/SIRT segment accounted for the largest share of the Interventional Oncology Market, by procedure, in 2018

Based on procedure, the Interventional Oncology Market is segmented into thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE) or selective internal radiation therapy (SIRT), and transcatheter arterial embolization (TAE) or bland embolization. In 2018, the TARE/SIRT procedures segment accounted for the largest market share majorly due to the rising prevalence of cancer, increasing demand for minimally invasive procedures, growing adoption of embolization procedures, and the clinical efficacy of Yttrium-90 radioembolic agents (which are used in these procedures).

Browse and in-depth TOC on "Interventional Oncology Market"

140 – Tables
33 – Figures
180 – Pages

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164

Liver cancer segment to register the highest CAGR in the Interventional Oncology Market, by application, during the forecast period

Based on cancer type, the Interventional Oncology Market is segmented into liver cancer, kidney cancer, lung cancer, bone cancer, and other cancers (includes pediatric cancer, prostate cancer, and breast cancer). Growth in this segment can be attributed to factors such as rising cases of liver cancer across the globe and growing initiatives/research activities for developing advanced liver cancer therapies using interventional oncology.

North America accounted for the largest share of the Interventional Oncology Market in 2018

The Interventional Oncology Market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the Interventional Oncology Market owing to factors such as the rising incidence of cancer, easy accessibility to interventional oncology, and the high adoption of technological advancements (owing to the significant per capita annual healthcare expenditure by the US government).

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=203687164

The major players operating in the Interventional Oncology Market are Medtronic (Ireland), Boston Scientific (US), BTG plc (UK), Merit Medical Systems (US), and Terumo (Japan). The other prominent players operating in the overall Interventional Oncology Market include AngioDynamics (US), Ethicon (part of J&J) (US), Teleflex (US), Cook Medical (US), HealthTronics (US), MedWaves Medical (US), Sanarus (US), IMBiotechnologies (Canada), Trod Medical (US), IceCure Medical (Israel), Mermaid Medicals (Denmark), and Interface Biomaterials BV (Netherlands).

Medtronic (Ireland) dominated the global interventional oncology market in 2017. The company focuses on adopting various organic growth strategies like product launches & approvals and inorganic growth strategies, such as acquisitions and collaborations, to expand its presence and share in the interventional oncology market.

Dental Bone Graft Substitutes Market worth $664.3 Million by 2021

According to a new market research report " Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), by Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), by Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021" , published by MarketsandMarkets, The global market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as technological advancements in the field of dental bone grafts and increase in the number of bone grafting procedures are expected to drive the growth of the global dental bone grafts substitutes market. Several insurance providers in the U.S. and various countries in the European region have assisted the medical sector to introduce and encourage the usage of latest synthetic bone grafts and demineralized allografts. This report mainly considers four type

Ostomy Care Accessories Market

The global ostomy care accessories market is projected to reach USD 2.99 billion by 2022 from USD 2.40 billion in 2017, at the CAGR of 4.5%. The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are some of the factors driving the growth of this market. The ostomy care accessories market is expected to grow at the highest CAGR during the forecast period owing to the growing skin problems due to frequent removal and re-application of skin barrier of ostomy bags and rising awareness about care of peristomal skin. Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=267183143 By system, the ostomy bags market is segmented into one-piece, two-piece, and skin barrier. Two-piece bags are expected to hold the

Cartilage Regeneration Market | Growth and Analysis, Industry Trends, Size, Shares, Forecast

The global cartilage regeneration market is projected to reach USD 779.8 Million by 2021 from USD 414.6 Million in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. Increase in obese population and rising incidence of sports injuries are the major factors driving the growth of cartilage regeneration market. However, high cost of therapy and unfavorable reimbursement scenario are the major factors that are restraining the growth of the market. The cartilage regeneration market is segmented on the basis of treatment modalities, application, and region. Based on treatment modalities, the market is segmented into cell based approaches and non-cell based approaches. Cell based approaches are further segmented into chondrocyte transplantation, growth factor technology, and stem cells. Non-cell based approaches are segmented into tissue scaffolds and cell-free composites. The cell based approaches segment is expected to account for the largest market share i

Medical Device | Healthcare | Biotechnology | Pharmaceuticals

Search This Blog